Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Day

Showing results (461-470 of 501) with videos related to

Pageof 51
Sort By:
The Medical Journal of Australia|June 9, 2005
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experienceDavid A Henry, Ian H Kerridge, Suzanne R Hill, et al.
British Journal of Clinical Pharmacology|April 19, 2017
Individualising the dose of allopurinol in patients with goutDiluk R W Kannangara, Garry G Graham, Daniel F B Wright, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|September 24, 2020
Healthcare expenditure and its predictors in a cohort of Australians living with sciaticaAlexander Chye, Chung-Wei Christine Lin, Mark J Hancock, et al.
Behavioural Brain Research|January 11, 2014
The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCDDawn M Eagle, Cristie Noschang, Laure-Sophie Camilla d'Angelo, et al.
Diabetes, Obesity & Metabolism|November 8, 2024
Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, et al.
British Journal of Clinical Pharmacology|July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementationIndy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
The Medical Journal of Australia|March 31, 2021
The efficacy and safety of paracetamol for pain relief: an overview of systematic reviewsChristina Abdel Shaheed, Giovanni E Ferreira, Alissa Dmitritchenko, et al.
Applied Clinical Informatics|April 2, 2025
Facilitators and Barriers to Uptake of Drug-Drug Interaction Alerts: Perspectives of Australian End Users and ManagersKristian Stanceski, Bethany A Van Dort, Teresa Lee, et al.
BMJ Open|August 21, 2019
Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alertsMelissa T Baysari, Wu Yi Zheng, Ling Li, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2020
The safety and pharmacokinetics of metformin in patients with chronic liver diseaseFelicity C Smith, Sophie L Stocker, Mark Danta, et al.
Pageof 51

Showing results (461-470 of 501) with videos related to

Sort By:
Pageof 51
The Medical Journal of Australia|June 9, 2005
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experienceDavid A Henry, Ian H Kerridge, Suzanne R Hill, et al.
British Journal of Clinical Pharmacology|April 19, 2017
Individualising the dose of allopurinol in patients with goutDiluk R W Kannangara, Garry G Graham, Daniel F B Wright, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|September 24, 2020
Healthcare expenditure and its predictors in a cohort of Australians living with sciaticaAlexander Chye, Chung-Wei Christine Lin, Mark J Hancock, et al.
Behavioural Brain Research|January 11, 2014
The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCDDawn M Eagle, Cristie Noschang, Laure-Sophie Camilla d'Angelo, et al.
Diabetes, Obesity & Metabolism|November 8, 2024
Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, et al.
British Journal of Clinical Pharmacology|July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementationIndy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
The Medical Journal of Australia|March 31, 2021
The efficacy and safety of paracetamol for pain relief: an overview of systematic reviewsChristina Abdel Shaheed, Giovanni E Ferreira, Alissa Dmitritchenko, et al.
Applied Clinical Informatics|April 2, 2025
Facilitators and Barriers to Uptake of Drug-Drug Interaction Alerts: Perspectives of Australian End Users and ManagersKristian Stanceski, Bethany A Van Dort, Teresa Lee, et al.
BMJ Open|August 21, 2019
Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alertsMelissa T Baysari, Wu Yi Zheng, Ling Li, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2020
The safety and pharmacokinetics of metformin in patients with chronic liver diseaseFelicity C Smith, Sophie L Stocker, Mark Danta, et al.
Pageof 51